RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Scott to Cell Line, Tumor

This is a "connection" page, showing publications John Scott has written about Cell Line, Tumor.
Connection Strength

0.229
  1. Kharabsheh HA, Scott JE. CoAsy knockdown in TNBC cell lines resulted in no overt effect on cell proliferation in?vitro. Biochem Biophys Res Commun. 2020 09 10; 530(1):136-141.
    View in: PubMed
    Score: 0.100
  2. Tarpley M, Abdissa TT, Johnson GL, Scott JE. Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines. Anticancer Res. 2014 Apr; 34(4):1629-35.
    View in: PubMed
    Score: 0.065
  3. Ahmad S, Carter JJ, Scott JE. A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity. Anal Biochem. 2010 May 01; 400(1):1-9.
    View in: PubMed
    Score: 0.048
  4. Kong R, Liu T, Zhu X, Ahmad S, Williams AL, Phan AT, Zhao H, Scott JE, Yeh LA, Wong ST. Old drug new use--amoxapine and its metabolites as potent bacterial ?-glucuronidase inhibitors for alleviating cancer drug toxicity. Clin Cancer Res. 2014 Jul 01; 20(13):3521-30.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support